Cetuximab for the treatment of metastatic colorectal cancer following failure of oxaliplatin-containing chemotherapy

  • Technology appraisal guidance
  • TA150
  • Published: 

This appraisal has been updated and replaced by NICE technology appraisal guidance 242.